• Complete Genomics Announces Commercial Partnership with Human Cell Atlas to Offer its Members Stereo-seq Spatial Transcriptomics at NextGen Omics & Spatial Biology Conference

  Mar 25, 2025Feb 10, 2026
• 

  Complete Genomics unveils DNBSEQ-T1+ and DNBSEQ-E25 Flash at AGBT 2025 General Meeting

  Feb 23, 2025Feb 10, 2026
• 

  2024 Year in Review: Complete Genomics’ Innovations and Impact

  Jan 9, 2025Feb 10, 2026
• 

  Complete Genomics Adds Eurofins Clinical Enterprise, LLC to its Sequencing Service Provider Program

  Dec 17, 2024Mar 10, 2025
• 

  Complete Genomics announces mpox virus amplicon sequencing panel at AMP

  Nov 20, 2024Feb 10, 2026
• 

  Complete Genomics Announces Spatial Omics Distributor Agreement, Debuts Spatial Xcellerator Grant Program at SITC 2024

  Nov 5, 2024Mar 10, 2025
• 

  Complete Genomics Highlights Innovation with Expanded Multi-Omics and Spatial Transcriptomics Applications at ASHG 2024

  Nov 4, 2024Mar 10, 2025
• 

  Complete Genomics integrates NVIDIA Parabricks to offer researchers faster, more cost-effective and accurate genomic sequencing analysis

  Oct 29, 2024Mar 12, 2025
• 

  AdvancedDx Biological Laboratories USA Inc. and Complete Genomics LLC to co-market NGS microbiology solution in the U.S.

  Sep 23, 2024Mar 12, 2025
• 

  Complete Genomics opens U.S. supply chain to genomic sequencing customers through a new manufacturing facility at its San Jose, Calif. headquarters 

  May 23, 2024Mar 10, 2025
• 

  Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston’s Biotech Hub 

  May 21, 2024Mar 10, 2025
• 

  Complete Genomics and seqWell Announce Partnership at AGBT 2024

  Feb 7, 2024Mar 12, 2025